|Videos|July 23, 2021

First Vyluma product tackles pediatric myopia

Dive deep into Vyluma’s investigational atropine therapy. Navneet Puri, PhD, the company’s founder, chairman, and CEO, explains details of the clinical trials.


Latest CME